Sangamo (SGMO): A short-term catalyst is coming up at CROI (Conference on Retroviruses and Opportunistic Infections), where sometime between Feb 27 - Mar 2, 2011, Sangamo will present the results from two (2) Phase 1 clinical trials on their HIV therapeutic.
Sangamo Biosciences created and developed the zinc finger technology and owns all the human therapeutic rights. They license out the technology to Sigma. Don't wait you don't want to be a "day late and a dollar short" call your broker now!
you know what happens to people who play god?
revolutionary17 3 months ago
Sangamo (SGMO): A short-term catalyst is coming up at CROI (Conference on Retroviruses and Opportunistic Infections), where sometime between Feb 27 - Mar 2, 2011, Sangamo will present the results from two (2) Phase 1 clinical trials on their HIV therapeutic.
Sangamo Biosciences created and developed the zinc finger technology and owns all the human therapeutic rights. They license out the technology to Sigma. Don't wait you don't want to be a "day late and a dollar short" call your broker now!
elwalvador 1 year ago
they have to do these tests on humans NOT animals
dalekdead 1 year ago
This sure is strange. I'd like to learn more about this. Wikipedia, here I come.
harvurd 2 years ago
All Hail Fncydansir!
Geronrocks1 2 years ago